Search

Your search keyword '"Duodenal Ulcer enzymology"' showing total 244 results

Search Constraints

Start Over You searched for: Descriptor "Duodenal Ulcer enzymology" Remove constraint Descriptor: "Duodenal Ulcer enzymology"
244 results on '"Duodenal Ulcer enzymology"'

Search Results

1. Iron deficiency anemia in cyclic GMP kinase knockout mice.

2. Bleeding diathesis and gastro-duodenal ulcers in inherited cytosolic phospholipase-A2 alpha deficiency.

3. The protective role of Aegle marmelos on aspirin-induced gastro-duodenal ulceration in albino rat model: a possible involvement of antioxidants.

4. Attenuation of cysteamine-induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A2/5-lipoxygenase and activating γ-glutamylcysteine synthetase.

5. Effect of andrographolide on cysteamine-induced duodenal ulcer in rats.

6. Antiulcer activity of Andrographis paniculata (Burm.f.) wall. against cysteamine-induced duodenal ulcer in rats.

7. Matrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected females.

8. [Substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones as inhibitors of urease].

9. Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan.

10. Candida albicans aggravates duodenal ulcer perforation induced by administration of cysteamine in rats.

11. [Parameters of plasma blood proteolysis and phenotypes of alpha1-proteinase inhibitor in children with duodenal ulcer].

12. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan.

13. [A non-invasive method of evaluation of Helicobacter pylori urease activity: its perfection and introduction to clinical practice].

14. [Oxidative stress in mechanism of psychosomatic disorders realization in duodenal ulcer in students].

15. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.

16. Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders.

17. Gastroduodenal safety of cyclooxygenase-2 inhibitors.

18. Phospholipase C activity of Helicobacter pylori is not associated with the presence of the cagA gene.

19. Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori.

20. Adenosine deaminase activity in the gastric mucosa of duodenal ulcer patients in relation to the severity of chronic gastritis and gastric acid secretion.

21. [Proteolytic activity of duodenal mucosa in elderly and senile patients in the presence of duodenal hemorrhage from ulcer].

22. [The pathogenetic aspects of an ulcerative lesion of the duodenal mucosa].

23. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons.

24. [Activity of gastric mucosal NO synthase in duodenal ulcer].

26. Increased COX-2, but not COX-1, mRNA expression in Helicobacter pylori gastritis.

27. [The effect of perftoran on the morphofunctional status of the digestive system organs in experimental duodenal ulcer].

28. Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase.

29. [The role of the enzymatic antioxidant system and Helicobacter pylori infection in the pathogenesis of peptic ulcer and their effect on treatment efficacy].

30. [The function of the digestive processes in the stomach and small intestine in complicated peptic ulcer].

31. [Lipid peroxidation and the role of quaternary ammonium compounds in normalizing this process].

32. [The efficacy of Kvamatel and Omez in correcting disorders of the antioxidant system of the digestive tract organs in experimental duodenal ulcer].

33. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.

34. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients.

35. Ceruloplasmin as an antioxidant in duodenal ulcers.

36. Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer.

37. Superoxide dismutase activity in duodenal ulcer patients.

39. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.

40. A cost analysis of alternative treatments for duodenal ulcer.

41. Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects.

42. Nitric oxide synthase in gastric mucosa.

44. [The histochemical and histoenzymological changes in the gastric mucosa and the state of the connective tissue in peptic ulcer patients during dynamic rehabilitative treatment].

45. [Intragastric proteolysis after selective proximal vagotomy].

46. Serum pepsinogen values as possible markers for evaluating the possibility of peptic ulcer recurrence under H2-blocker half-dose maintenance therapy.

47. Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients.

48. Phospholipase A2 activity in gastric juice from patients with active and H. pylori-eradicated healed duodenal ulcer.

49. Subsite study of human pepsin in disease.

50. Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients.

Catalog

Books, media, physical & digital resources